Drug Profile
Research programme: temperature-stable liquid insulin - Cambridge Biostability
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cambridge Biostability
- Class
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in United Kingdom (Parenteral, Injection)
- 29 May 2007 Preclinical trials in Diabetes mellitus in United Kingdom (Parenteral)